Patent application number | Description | Published |
20090047737 | Human LY6-Big Molecules and Methods of Use - The present invention is directed to human Ly6-BIG molecules and their use in diagnostic, prognostic, and treatment methods for colon, lung and other cancers, in preventing the reoccurrence of such cancers, and in diagnostic, prognostic, and treatment methods for autoimmune disorders and AIDS. | 02-19-2009 |
20120064080 | Human LY6-Big Molecules and Methods of Use - The present invention is directed to human Ly6-BIG molecules and their use in diagnostic, prognostic, and treatment methods for colon, lung and other cancers, in preventing the reoccurrence of such cancers, and in diagnostic, prognostic, and treatment methods for autoimmune disorders and AIDS. | 03-15-2012 |
20130244268 | CANCER STEM CELLS EXPRESSING ABCG2 - Cancer Stem Cell populations characterized by expression of ABCG2 and methods of isolating and using the same are disclosed. | 09-19-2013 |
20140256041 | METHODS OF BLOCKING CANCER STEM CELL GROWTH - Disclosed herein are antibodies against GPR49 and uses of such antibodies. The antibodies can be monoclonal, humanized, or fully human antibodies against GPR49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies, and methods of blocking cancer stem cell growth with such antibodies. | 09-11-2014 |
20140302049 | ANTI-GPR49 ANTIBODIES - Described herein are to antibodies against GPR49 and uses of such antibodies. Various aspects relate to monoclonal, humanized, or fully human antibodies against GPR49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies. | 10-09-2014 |
20140302054 | ANTI-GPR49 ANTIBODIES - Described herein are antibodies against GPR49 and uses of such antibodies. Various aspects relate to monoclonal, humanized, or fully human antibodies against GPR49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies. | 10-09-2014 |
20150017677 | CANCER STEM CELLS - Cancer stem cell populations characterized by expression of CD44 | 01-15-2015 |
20150037324 | ANTIBODIES AND METHODS OF TREATING CANCER - Described herein are antibodies against GPR49 and uses of such antibodies. Various aspects relate to monoclonal, humanized, or fully human antibodies against GPR49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies, and methods of treating cancer with such antibodies. | 02-05-2015 |